Skip to content

Medication Adherence in Geriatrics with Type 2 Diabetes through Real Time Medication Monitoring and Clinical Pharmacological Reconciliation

Evaluation of Medication Adherence in Geriatric Patients with Type 2 Diabetes through Real time Monitoring & Clinical Pharmacological Reconciliation: A Multi-Centre Randomized Controlled Trial - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058703
Enrollment
360
Registered
2023-10-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Medicinal Adherence Kit Development: MedpeR - personal Medicinal helper: Medicinal Adherence Kit Development: MedpeR - personal Medicinal helper Intervention2: Clinical Pharmacological
2. De-prescribing of medicines that are unnecessary or redundant or contraindicated or not well tolerated
3.Identifying omissions and commissions during transition of care
4. Tailoring the dose adjusting to the individual need and perspectives 5. Preventing, minimizing and managing adverse drug reactions (ADRs)
6.Improving treatment adherence
7. Considering affordability and availability of medicines vis-à-vis adherence 8. Individualization of treatment accommodating patient factors
9.Rationalising polypharmacy
10.Enhancing quality of life. Control Intervention1: Standard of Care: Standard of Care for 12 months

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with T2DM on oral antidiabetic agents having a having a medication adherence rate of less than 80% in the last 12 months

Exclusion criteria

Exclusion criteria: Those patient with T2DM on oral antidiabetic agents having a medication adherence rate of more than 80% in the last 12 months

Design outcomes

Primary

MeasureTime frame
Medication adherence rate (pill counting method)Timepoint: Every three months, for a period of one year

Secondary

MeasureTime frame
Adverse Drug ReactionsTimepoint: Every three months, for a period of one year

Countries

India

Contacts

Public ContactShatavisa MUkherjee

School of Tropical Medicine

shatavisa100@gmail.com7003776138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026